Vidipha Central Pharmaceutical JSC (HOSE:VDP)
47,000
+50 (0.11%)
At close: Jan 16, 2026
HOSE:VDP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2008 | FY 2007 |
|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 |
Cash & Equivalents | 213,988 | 88,123 | 18,666 | 59,208 |
Short-Term Investments | 119,000 | 209,692 | 54,500 | - |
Cash & Short-Term Investments | 332,988 | 297,815 | 73,166 | 59,208 |
Cash Growth | 11.81% | 307.04% | 23.57% | - |
Accounts Receivable | 199,693 | 187,387 | 41,717 | 38,217 |
Other Receivables | 19,523 | 24,175 | 42.49 | 256.79 |
Receivables | 219,216 | 212,187 | 41,760 | 40,160 |
Inventory | 296,736 | 341,329 | 33,507 | 33,242 |
Prepaid Expenses | 2,019 | 373.94 | 1.42 | - |
Other Current Assets | 24,058 | 63,986 | 3,558 | 10,238 |
Total Current Assets | 875,016 | 915,692 | 151,992 | 142,847 |
Property, Plant & Equipment | 172,255 | 151,140 | 26,045 | 29,442 |
Long-Term Investments | 5,000 | 5,010 | 4,165 | 4,325 |
Other Intangible Assets | 38,926 | 27,822 | 9,236 | - |
Other Long-Term Assets | 1,245 | 204.32 | - | - |
Total Assets | 1,093,445 | 1,102,194 | 191,437 | 176,614 |
Accounts Payable | 36,594 | 71,407 | 13,074 | 8,884 |
Accrued Expenses | 40,518 | 53,455 | 1,356 | 2,653 |
Short-Term Debt | 273,139 | 336,307 | - | - |
Current Income Taxes Payable | - | 4,736 | 674.91 | 1,338 |
Other Current Liabilities | 11,211 | 9,696 | 6,658 | 2,073 |
Total Current Liabilities | 361,463 | 475,601 | 21,762 | 14,947 |
Other Long-Term Liabilities | - | - | 292.48 | 236.26 |
Total Liabilities | 361,463 | 475,601 | 22,055 | 15,184 |
Common Stock | 184,029 | 168,319 | 60,000 | 60,000 |
Additional Paid-In Capital | 216,657 | 176,040 | 61,803 | 61,803 |
Retained Earnings | 331,296 | 282,235 | 33,916 | 24,945 |
Comprehensive Income & Other | - | - | 13,664 | 14,683 |
Shareholders' Equity | 731,982 | 626,593 | 169,382 | 161,431 |
Total Liabilities & Equity | 1,093,445 | 1,102,194 | 191,437 | 176,614 |
Total Debt | 273,139 | 336,307 | - | - |
Net Cash (Debt) | 59,848 | -38,491 | 73,166 | 59,208 |
Net Cash Growth | - | - | 23.57% | - |
Net Cash Per Share | 2963.04 | -1905.67 | 10160.92 | 8963.90 |
Filing Date Shares Outstanding | 22.08 | 20.2 | 7.2 | 6.61 |
Total Common Shares Outstanding | 22.08 | 20.2 | 7.2 | 6.61 |
Working Capital | 513,553 | 440,091 | 130,230 | 127,900 |
Book Value Per Share | 33146.14 | 31022.11 | 23525.33 | 24440.29 |
Tangible Book Value | 693,056 | 598,772 | 160,147 | 161,431 |
Tangible Book Value Per Share | 31383.47 | 29644.68 | 22242.61 | 24440.29 |
Buildings | 149,233 | 124,746 | 23,592 | 22,843 |
Machinery | 251,362 | 217,337 | 42,578 | 41,403 |
Construction In Progress | 203.75 | 11,500 | 239.83 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.